Genetic Testing FAQs
Answers to common questions about genetic testing for cancer.
Answers to common questions about genetic testing for cancer.
The first genetic test for cancer became available in 1996. That test, the BRCA 1/2 test, looked for mutations in the two genes most commonly affected in hereditary breast and ovarian cancer — the breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) genes. Since then, many more cancer genes have been identified, and tests developed to look for mutations.
A new type of scan is helping doctors at The Harold Leever Regional Cancer Center detect very small, hard-to-find areas of prostate cancer, which could lead to better treatment outcomes.
Americans spend more than $30 billion a year on vitamins, herbals and other supplements. It is not uncommon for our patients to arrive to their oncology consultations with a large bag (or long list) of the supplements they are taking. It has been estimated that 65%-80% of all cancer patients take one or more vitamin or mineral supplements, and many of these patients START taking supplements just prior to starting their treatment.
Excluding skin cancers, colorectal cancer is the third most common cancer diagnosed in both men and women in the United States. In 2022, approximately 106,180 people will be diagnosed with colon cancer and 44,850 with rectal cancer, according to estimates from the American Cancer Society.
Should you put off your cancer screenings? Experts agree the answer in most cases is “definitely not.” Here’s why:
Many people are still reluctant to get cancer screenings or treatment, but experts suggest you consider several factors before making a decision.
“Fear of contracting the coronavirus in health care settings has dissuaded people from screening, diagnosis, and treatment,” Norman E. Sharpless, MD, director of the National Cancer Institute, wrote in Science magazine. “In general, the earlier one receives cancer treatment, the better the results. Cancers being missed now will still come to light eventually, but at a later stage and with worse prognoses.”
Lung cancer is the third most common cancer in the United States, with an estimated 228,820 new cases diagnosed in 2020 according to the American Cancer Society. If you or a loved one has been diagnosed with lung cancer, or if you want to learn about lung cancer screenings and how to prevent or treat lung cancer, here’s what you need to know.
A cancer diagnosis is never good news, but for U.S. residents, a cancer diagnosis is more survivable than ever before.